October 25, 2021 (Reuters) – Moderna Inc (MRNA.O) said on Monday, October 25th, its COVID-19 vaccine generated a strong immune response in children aged …
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept